Leadership

Photo of Doug Earle

A Message From The President & CEO

For 45 years, the Foundation Fighting Blindness has led the fight against blindness by raising funds and directing research aimed at preventing vision loss and restoring sight to people living with blinding eye diseases.

Today, we’re at a unique moment in history, where the research we’re funding has begun to translate into clinical care that is preventing vision loss.  With the support of our community, we are moving closer to treatments and cures for blinding eye diseases.

It gives me great pleasure to welcome you to our website, where you can find information about the blinding eye diseases that over 5.5 million people across Canada are at risk of developing. Here, learn about the cutting-edge research we’re funding into the causes, treatments and cures for vision loss. For people living with vision loss, our Vision Care Pathways are a comprehensive, centralized resource offering guidance and information specific to different eye diseases. Our Patient Registry for inherited retinal diseases connects people living with retinal eye diseases to emerging clinical trials and research. And of course, we welcome people to join our national fundraisers, supported by an incredible community of donors and volunteers determined to help make blindness a thing of the past.

Thank you for visiting the Foundation Fighting Blindness. Together, we can restore hope and sight.

Doug Earle's signature

 

 

 

Doug Earle

President & CEO

The Foundation Fighting Blindness

Board of Directors

Our Board of Directors is a group of volunteers committed to the Foundation’s mission to find a cure for retinitis pigmentosa, macular degeneration and related diseases of the retina. The Board includes representatives from the corporate and medical worlds, as well as individuals affected by vision loss.

Executive Committee & Officers

Andrew Burke, Chair Partner, Steward McKelvey Halifax, Nova Scotia

Joe Grech, Vice-Chair Vancouver, British Columbia

Rahn Dodick, Treasurer President, Dodick, Landau, Inc. Toronto, Ontario

Malcolm Hunter, Corporate Secretary President, Fred Deeley Limited Vancouver, British Columbia

Tara James, Executive Officer Senior Counsel, BMO Financial Group Toronto, Ontario

Robert F. Richards, Executive Officer Chairman, Heathbridge Capital Management Ltd. Toronto, Ontario

Catherine Tillmann, Executive Officer Director of Brand Image, Corporate Marketing, Four Seasons Hotels and Resorts (retired) Toronto, Ontario

Directors

Stephen Aylward Lawyer, Stockwoods LLP Toronto, Ontario

Michel Cayouette, PhD Research Unit Director, Institut de recherche cliniques de Montreal (IRCM) Research Associate Professor, University of Montreal Montreal, Quebec

David Drury Managing Director, IBM Canada Ltd. Toronto, Ontario

Jane Humphreys Toronto, Ontario

Peter J. Kertes, MD, FRCSC Vitreo-retinal surgeon/Ophthalmologist-in-Chief, Sunnybrook Health Sciences Centre Professor of Ophthalmology & Vision Sciences, University of Toronto Toronto, Ontario

Donald F. Reed President and CEO, Franklin Templeton Investments Corp. (retired) Toronto, Ontario

Mike Seed, CIM First Vice President & Portfolio Manager, Seed Financial Group, CIBC Wood Gundy Edmonton, Alberta

George Sheen Partner, PwC (retired) Toronto, Ontario

Rob Simmons Vice President, Finance & Business Affairs, Atomic Cartoons Vancouver, British Columbia

Raymond M. Stein, MD, FRCSC Medical Director, Bochner Eye Institute Toronto, Ontario

Deborah Tennant Toronto, Ontario

Scientific Advisory Board

The Foundation Fighting Blindness Scientific Advisory Board (SAB) is a group of highly qualified and committed volunteers. These scientists bring a wide range of expertise to the FFB’s scientific decision-making in genetics, molecular genetics, molecular biology, biochemistry and cell biology. All are actively engaged in sight-saving research. The SAB is responsible for evaluating research applications submitted to the FFB’s annual grant competition(s). SAB members also aid in promoting retinal disease research amongst the scientific community and support the quality and accuracy of our educational programs and materials. Rigorous review for scientific merit by the SAB ensures that dollars donated to the FFB are used to fund the most productive and promising research projects, addressing crucial questions about the causes and treatment of retinal degenerative diseases. Thanks to the guidance of our scientific advisory boards, past and present, scientists funded by the FFB have consistently accomplished their research goals and have been responsible for major research breakthroughs.  

Michel Cayouette, PhD (Chair) Professor and Director of the Cellular Neurobiology Research Unit, Gaëtane and Roland Pillenière Chair in Retina Research, Montreal Clinical Research Institite (IRCM) Research Professor, Université de Montréal Adjunct Professor, McGill University

Robin Ali, PhD Professor of Human Molecular Genetics, University College London

Seth Blackshaw, PhD Professor of Neuroscience, Johns Hopkins School of Medicine

Sylvain Chemtob, MD, PhD Professor, Pediatrics, Ophthalmology and Pharmacology, University of Montreal Canada Research Chair in Vision, Tier 1

Bob Chow, PhD Associate Professor, Department of Biology, University of Victoria

David Gamm, MD, PhD Associate Professor, RRF Emmett A. Humble Distinguished Director, McPherson Eye Research Institute, Waisman Center Stem Cell Research Program

Tony Moore, FRCOphth, FMedSci Michal Vilensky Endowed Chair in Ophthalmology UCSF School of Medicine San Francisco

Przemyslaw (Mike) Sapieha, Ph.D. Wolfe Professorship in Translational Vision Research 2016 Associate Professor, Maisonneuve-Rosemont Research Centre, University of Montreal

Carol Schuurmans, PhD Senior scientist, Dixon Family Chair in Ophthalmology, Sunnybrook Research Institute

Janey Wiggs, MD, PhD Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School Vice Chair and Associate Chief, Ophthalmology Clinical Research; Associate Director, Ocular Genomics Institute, Massachusetts Eye and Ear, Harvard University

Don Zack, MD, PhD Co-director, Johns Hopkins Center for Stem Cells and Ocular Regenerative Medicine (STORM), Johns Hopkins Medicine

Dr. Mary Sunderland Mary Sunderland, PhD (non-voting member) Director of Research & Education for the Foundation Fighting Blindness